{"name":"Laboratorios Sophia S.A de C.V.","slug":"laboratorios-sophia-sa-de-cv","ticker":"","exchange":"","domain":"laboratoriossophiasadecv.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"oncology","drugs":[{"name":"Sodium hyaluronate 0.4%","genericName":"Sodium hyaluronate 0.4%","slug":"sodium-hyaluronate-0-4","indication":"Other","status":"marketed"},{"name":"Artelac","genericName":"Artelac","slug":"artelac","indication":"Other","status":"phase_1"},{"name":"Corneregel","genericName":"Corneregel","slug":"corneregel","indication":"Other","status":"phase_1"},{"name":"Krytantek","genericName":"Krytantek","slug":"krytantek","indication":"Other","status":"discontinued"},{"name":"Manzanilla Sophia®","genericName":"Manzanilla Sophia®","slug":"manzanilla-sophia","indication":"Other","status":"marketed"},{"name":"PRO-087","genericName":"PRO-087","slug":"pro-087","indication":"Other","status":"marketed"},{"name":"PRO-155","genericName":"PRO-155","slug":"pro-155","indication":"Other","status":"marketed"},{"name":"PRO-167","genericName":"PRO-167","slug":"pro-167","indication":"Other","status":"phase_1"},{"name":"Prednefrin","genericName":"Prednefrin","slug":"prednefrin","indication":"Other","status":"phase_3"},{"name":"Zymar®","genericName":"Zymar®","slug":"zymar","indication":"Other","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"cardiovascular","drugs":[{"name":"PRO-148","genericName":"PRO-148","slug":"pro-148","indication":"Dry eye disease","status":"phase_3"},{"name":"Alleance®","genericName":"Alleance®","slug":"alleance","indication":"Dry eye disease (keratoconjunctivitis sicca)","status":"phase_3"},{"name":"Meticel Ofteno®","genericName":"Meticel Ofteno®","slug":"meticel-ofteno","indication":"Dry eye syndrome","status":"marketed"},{"name":"Krytantek Ofteno®","genericName":"Krytantek Ofteno®","slug":"krytantek-ofteno","indication":"Glaucoma (intraocular pressure reduction)","status":"phase_3"},{"name":"Meticel Ofteno® 0.5%","genericName":"Meticel Ofteno® 0.5%","slug":"meticel-ofteno-0-5","indication":"Dry eye syndrome / Keratoconjunctivitis sicca","status":"marketed"},{"name":"Optive®","genericName":"Optive®","slug":"optive","indication":"Dry eye disease / Keratoconjunctivitis sicca","status":"marketed"},{"name":"Sodium Hyaluronate Ophthalmic 0.4%","genericName":"Sodium Hyaluronate Ophthalmic 0.4%","slug":"sodium-hyaluronate-ophthalmic-0-4","indication":"Dry eye syndrome / Keratoconjunctivitis sicca","status":"marketed"},{"name":"Sodium hyaluronate 0.15%","genericName":"Sodium hyaluronate 0.15%","slug":"sodium-hyaluronate-0-15","indication":"Dry eye syndrome","status":"marketed"},{"name":"Systane Ultra Preservative Free","genericName":"Systane Ultra Preservative Free","slug":"systane-ultra-preservative-free","indication":"Dry eye disease / Keratoconjunctivitis sicca","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Dorzolamide-timolol-brimonidine and latanoprost","genericName":"Dorzolamide-timolol-brimonidine and latanoprost","slug":"dorzolamide-timolol-brimonidine-and-latanoprost","indication":"Open-angle glaucoma","status":"marketed"},{"name":"Dorzolamide-timolol and latanoprost","genericName":"Dorzolamide-timolol and latanoprost","slug":"dorzolamide-timolol-and-latanoprost","indication":"Open-angle glaucoma","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Moxifloxacin / Dexamethasone Ophthalmic Solution","genericName":"Moxifloxacin / Dexamethasone Ophthalmic Solution","slug":"moxifloxacin-dexamethasone-ophthalmic-solution","indication":"Bacterial conjunctivitis","status":"phase_3"},{"name":"Moxifloxacin Hydrochloride, Ophthalmic","genericName":"Moxifloxacin Hydrochloride, Ophthalmic","slug":"moxifloxacin-hydrochloride-ophthalmic","indication":"Bacterial conjunctivitis","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Difluprednate 0.05%","genericName":"Difluprednate 0.05%","slug":"difluprednate-0-05","indication":"Inflammation and pain following ocular surgery","status":"phase_3"}]}],"pipeline":[{"name":"Sodium hyaluronate 0.4%","genericName":"Sodium hyaluronate 0.4%","slug":"sodium-hyaluronate-0-4","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dorzolamide-timolol-brimonidine and latanoprost","genericName":"Dorzolamide-timolol-brimonidine and latanoprost","slug":"dorzolamide-timolol-brimonidine-and-latanoprost","phase":"marketed","mechanism":"This fixed-dose combination reduces intraocular pressure through four complementary mechanisms: carbonic anhydrase inhibition, beta-adrenergic blockade, alpha-2 adrenergic agonism, and prostaglandin F analog activity.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"PRO-148","genericName":"PRO-148","slug":"pro-148","phase":"phase_3","mechanism":"PRO-148 is an ophthalmic anti-inflammatory agent designed to reduce ocular surface inflammation and associated symptoms.","indications":["Dry eye disease"],"catalyst":""},{"name":"Alleance®","genericName":"Alleance®","slug":"alleance","phase":"phase_3","mechanism":"Alleance® is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease (keratoconjunctivitis sicca)"],"catalyst":""},{"name":"Artelac","genericName":"Artelac","slug":"artelac","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dorzolamide-timolol and latanoprost","genericName":"Dorzolamide-timolol and latanoprost","slug":"dorzolamide-timolol-and-latanoprost","phase":"marketed","mechanism":"This combination reduces intraocular pressure through three mechanisms: dorzolamide inhibits carbonic anhydrase to decrease aqueous humor production, timolol blocks beta-adrenergic receptors to reduce aqueous humor secretion, and latanoprost increases uveoscleral outflow of aqueous humor.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Meticel Ofteno®","genericName":"Meticel Ofteno®","slug":"meticel-ofteno","phase":"marketed","mechanism":"Meticel Ofteno is a topical ophthalmic preparation containing methylcellulose that lubricates and protects the ocular surface.","indications":["Dry eye syndrome","Ocular irritation and discomfort","Lubricant for ophthalmic procedures"],"catalyst":""},{"name":"Corneregel","genericName":"Corneregel","slug":"corneregel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Difluprednate 0.05%","genericName":"Difluprednate 0.05%","slug":"difluprednate-0-05","phase":"phase_3","mechanism":"Difluprednate is a potent corticosteroid that suppresses inflammatory and immune responses in the eye by binding to glucocorticoid receptors.","indications":["Inflammation and pain following ocular surgery","Anterior uveitis","Allergic conjunctivitis","Corneal injury"],"catalyst":""},{"name":"Krytantek","genericName":"Krytantek","slug":"krytantek","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Krytantek Ofteno®","genericName":"Krytantek Ofteno®","slug":"krytantek-ofteno","phase":"phase_3","mechanism":"Krytantek Ofteno is a topical ophthalmic formulation designed to reduce intraocular pressure in glaucoma by enhancing aqueous humor outflow or reducing aqueous humor production.","indications":["Glaucoma (intraocular pressure reduction)"],"catalyst":""},{"name":"Manzanilla Sophia®","genericName":"Manzanilla Sophia®","slug":"manzanilla-sophia","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Meticel Ofteno® 0.5%","genericName":"Meticel Ofteno® 0.5%","slug":"meticel-ofteno-0-5","phase":"marketed","mechanism":"Meticel Ofteno is a topical ophthalmic solution containing methylcellulose that acts as a lubricating and protective agent for the ocular surface.","indications":["Dry eye syndrome / Keratoconjunctivitis sicca","Ocular surface protection and lubrication"],"catalyst":""},{"name":"Moxifloxacin / Dexamethasone Ophthalmic Solution","genericName":"Moxifloxacin / Dexamethasone Ophthalmic Solution","slug":"moxifloxacin-dexamethasone-ophthalmic-solution","phase":"phase_3","mechanism":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while dexamethasone is a corticosteroid that reduces inflammation in the eye.","indications":["Bacterial conjunctivitis","Post-operative ocular inflammation and infection","Corneal ulcers with bacterial infection"],"catalyst":""},{"name":"Moxifloxacin Hydrochloride, Ophthalmic","genericName":"Moxifloxacin Hydrochloride, Ophthalmic","slug":"moxifloxacin-hydrochloride-ophthalmic","phase":"phase_3","mechanism":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible microorganisms.","indications":["Bacterial conjunctivitis","Bacterial keratitis","Bacterial corneal ulcer","Post-operative ocular infections"],"catalyst":""},{"name":"Optive®","genericName":"Optive®","slug":"optive","phase":"marketed","mechanism":"Optive is an artificial tear solution that lubricates and protects the ocular surface to relieve symptoms of dry eye disease.","indications":["Dry eye disease / Keratoconjunctivitis sicca"],"catalyst":""},{"name":"PRO-087","genericName":"PRO-087","slug":"pro-087","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PRO-155","genericName":"PRO-155","slug":"pro-155","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PRO-167","genericName":"PRO-167","slug":"pro-167","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Prednefrin","genericName":"Prednefrin","slug":"prednefrin","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sodium Hyaluronate Ophthalmic 0.4%","genericName":"Sodium Hyaluronate Ophthalmic 0.4%","slug":"sodium-hyaluronate-ophthalmic-0-4","phase":"marketed","mechanism":"Sodium hyaluronate acts as a lubricating and hydrating agent that coats the ocular surface to relieve dry eye symptoms.","indications":["Dry eye syndrome / Keratoconjunctivitis sicca","Ocular surface irritation and discomfort"],"catalyst":""},{"name":"Sodium hyaluronate 0.15%","genericName":"Sodium hyaluronate 0.15%","slug":"sodium-hyaluronate-0-15","phase":"marketed","mechanism":"Sodium hyaluronate is a viscoelastic substance that lubricates and protects the ocular surface by mimicking natural tear film.","indications":["Dry eye syndrome","Ocular surface protection during ophthalmic surgery","Post-operative ocular surface care"],"catalyst":""},{"name":"Systane Ultra Preservative Free","genericName":"Systane Ultra Preservative Free","slug":"systane-ultra-preservative-free","phase":"marketed","mechanism":"Systane Ultra Preservative Free is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms.","indications":["Dry eye disease / Keratoconjunctivitis sicca","Ocular surface irritation and discomfort"],"catalyst":""},{"name":"Zymar®","genericName":"Zymar®","slug":"zymar","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":24,"phaseCounts":{"marketed":13,"phase_3":7,"phase_1":3,"discontinued":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}